Fintel reports that on March 25, 2025, Stephens & Co. downgraded their outlook for Akoya Biosciences (NasdaqGS:AKYA) from ...

This article was originally published on Quiver News, read the full story. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of ...

Explore Akoya Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for AKYA. Jim Cramer Says This Major Automotive Stock Is Just Too Cheap ...

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) saw a large decline in short interest in March. As of March 15th, there was short interest totalling 2,490,000 shares, a decline of 30.8% from ...

Akoya Biosciences (NASDAQ:AKYA – Get Free Report) is projected to post its quarterly earnings results after the market closes on Monday, March 31st. Analysts expect Akoya Biosciences to post earnings ...

Tikvah Management, which owns approximately 1.5% of the outstanding common shares of Quanterix (QTRX) intends to vote against the company’s ...

Stephens downgraded Akoya Biosciences (AKYA) to Equal Weight from Overweight with a price target of $1.80, down from $3.50, given the pending ...

Quanterix issued the following statement: Quanterix’s proposed acquisition of Akoya is the result of a rigorous and thorough Board evaluation consistent with its commitment to position the ...

Akoya Biosciences (AKYA) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.22 per share a year ago. These ...

MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Akoya Biosciences Inc. (AKYA) on Monday reported a loss of $8.2 million in its fourth quarter. On a per-share basis, the Marlborough, ...